COGT logo

COGT
Cogent Biosciences Inc

3,215
Mkt Cap
$5.95B
Volume
1.95M
52W High
$43.73
52W Low
$4.55
PE Ratio
-14.32
COGT Fundamentals
Price
$36.63
Prev Close
$35.79
Open
$35.81
50D MA
$36.50
Beta
1.56
Avg. Volume
2.1M
EPS (Annual)
-$2.55
P/B
10.79
Rev/Employee
$0.00
$4,008.57
Loading...
Loading...
News
all
press releases
Teachers Retirement System of The State of Kentucky Invests $1.33 Million in Cogent Biosciences, Inc. $COGT
Teachers Retirement System of The State of Kentucky purchased a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 37,445 shares of the technology company's stock...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Cogent Biosciences, Inc. (NASDAQ:COGT) Sees Large Drop in Short Interest
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totaling 12,038,491 shares...
MarketBeat·5d ago
News Placeholder
Cogent Biosciences (COGT) Expected to Announce Quarterly Earnings on Tuesday
Cogent Biosciences (NASDAQ:COGT) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-cogent-biosciences-inc-stock-1...
MarketBeat·5d ago
News Placeholder
Cogent Biosciences (NASDAQ:COGT) Shares Cross Above Fifty Day Moving Average - Should You Sell?
Cogent Biosciences (NASDAQ:COGT) Stock Price Passes Above Fifty Day Moving Average - Here's Why...
MarketBeat·11d ago
News Placeholder
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Rating of "Moderate Buy" by Analysts
Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the fourteen brokerages that are covering the company, MarketBeat reports. One...
MarketBeat·24d ago
News Placeholder
Cogent Biosciences (NASDAQ:COGT) Stock Price Down 10.2% - Should You Sell?
Cogent Biosciences (NASDAQ:COGT) Shares Down 10.2% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Biotech Stocks To Consider - April 1st
Moderna, Danaher, and Cogent Biosciences are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that use biological science...
MarketBeat·1mo ago
News Placeholder
Cogent Biosciences Stock Falls 6% After Submission Of New Drug Application For Bezuclastinib
(RTTNews) - Stock of Cogent Biosciences, Inc. (COGT) is falling about 6 percent on Wednesday morning trading after the submission of its New Drug Application to the U.S. Food and Drug Administration for bezuclastinib in patients with Gastrointestinal Stromal Tumors...
Nasdaq News: Markets·1mo ago
News Placeholder
Hennion & Walsh Asset Management Inc. Buys 37,938 Shares of Cogent Biosciences, Inc. $COGT
Hennion & Walsh Asset Management Inc. increased its position in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 12.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 338,065 shares of the technology c...
MarketBeat·1mo ago
News Placeholder
Assenagon Asset Management S.A. Trims Stock Holdings in Cogent Biosciences, Inc. $COGT
Assenagon Asset Management S.A. cut its holdings in Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 34.9% in the 4th quarter, according to the company in its most recent filing with the...
MarketBeat·1mo ago
<
1
2
...
>

Latest COGT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.